Mistelihoidon yhteisvaikutus muiden syöpähoitojen kanssa
Immuunivastetta muuntava hoito
Thronicke A, Grabowski P, Roos J, Wüstefeld H, Grah C, Johnson S, Schad F. Combined Immune Checkpoint Blockade and Helixor® Therapy in Oncology: Real-World Tolerability and Subgroup Survival (ESMO GROW). Int J Mol Sci. 2025 Apr 12;26(8):3669. doi: 10.3390/ijms26083669. PMID: 40332249; PMCID: PMC12027740.
https://pubmed.ncbi.nlm.nih.gov/40332249/
Schad, F., Thronicke, A., Hofheinz, R.-D., Matthes, H., & Grah, C. (2024). Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study. Cancers, 16(8), 1609.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11049173/pdf/cancers-16-01609.pdf
Fuller-Shavel, N., & Krell, J. (2024). Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours. Curr Oncol Rep, 26(2), 164-174. https://doi.org/10.1007/s11912-023-01492-4
Werthmann PG, Kindermann L, Kienle GS. Chemoimmunotherapy in Advanced Renal Cell Carcinoma: A Case Report of a Long-Term Survivor Adjunctly Treated with Viscum album Extracts. Complementary Medicine Research. March 2019:1-4. DOI:10.1159/000496866 .
Grah C, Kurzeja A, Matthes B, Eichberger A, Wüstfeld A, Kunc K, Weissenstein U, Thieme C, Müssig A, Schad F and Reif M. Immun-Checkpoint-Inhibition plus Viscum album L.- Extrakt beim Lungenkarzinom. Conference: 60 Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., 2019.
Pneumologie 2019; 73(S 01) DOI: 10.1055/s-0039-1678248
Drozdoff L, Klein E, Kalder M, Brambs C, Kiechle M, Paepke D. Potential interactions of biologically based complementary medicine in gynecological oncology. Integrative Cancer Therapies 2019: 18(10) pp. DOI: 10.1177/1534735419846392.
Thronicke A, Oei S L, Merkle A, Matthes H and Schad F. Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients. Medicines (Basel), 2018;5. DOI: 10.3390/medicines5030100
Thronicke A, Steele M L, Grah C, Matthes B and Schad F. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. BMC Complement Altern Med, 2017;17:534. DOI: 10.1186/s12906-017-2045-0